Oxea increases manufacturing capacity
Syngas is the key precursor for the production of oxo intermediates and oxo derivatives, which are used in pharmaceutical products. The manufacturing facility develops oxo chemicals, synthetic fatty
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.